Autopsy report · NCT04036721

Coorticosteroid Regimen in Patients With Anti-PD-1/PD-L1 Induced Pneumonitis

“SARS-CoV-2 cases stopped the recruitment in Organisation since July 2020”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Suspended: paused, and may or may not restart.
• 85 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Phase

Phase 4

Sponsor

National Institute for Tuberculosis and Lung Diseases, Poland

Sponsor type

University, hospital or other

Conditions

Lung Neoplasm Malignant; Interstitial Lung Disease

Interventions

Prolonged glucocorticosteroid (prednisone) regimen; Short glucocorticosteroid (prednisone) regimen

Participants

85 (planned, not actual)

Sites

1

Countries

Poland

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.